NCT01809327 – A Randomized, Double-Blind, 5-Arm, Parallel-Group, 26-Week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in Combination With Metformin as Initial Combination Therapy in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise Posted on October 26, 2017 by tsuperadmin -
NCT02113579 – Assessment of potassium oxalate containing formulation for the relief of dentinal hypersenstivity Posted on August 31, 2017 by tsuperadmin -
NCT01727258 – Evaluation of an experimental mouth rinse device for relieving dentinal hypersenstivity Posted on August 31, 2017 by tsuperadmin -
NCT01345292 – Assessment of a potassium oxalate containing formulation for the relief of dentinal sensitivity Posted on August 31, 2017 by tsuperadmin -
NCT01156376 – Determination of the oral irritation and sensitization potential of two experimental potassium oxalate containing mouth rinses Posted on August 31, 2017 by tsuperadmin -
NCT01137812 – A Randomized, Double-Blind, Active-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin Versus Sitagliptin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sulphonylurea Therapy Posted on October 20, 2014 by Jessica Ritchie -
NCT01106690 – A Randomized, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sulphonylurea Therapy Posted on October 20, 2014 by tsuperadmin -
NCT01106651 – A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin Compared With Placebo in the Treatment of Older Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Glucose Lowering Therapy Posted on October 20, 2014 by tsuperadmin -
NCT00968812 – A Randomized, Double-Blind, 3-Arm Parallel-Group, 2-Year (104-Week), Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-28431754 Compared With Glimepiride in the Treatment of Subjects With Type 2 Diabetes Mellitus Not Optimally Controlled on Metformin Monotherapy Posted on October 20, 2014 by tsuperadmin -
NCT01106677 – A Randomized, Double-Blind, Placebo and Active-Controlled, 4-Arm, Parallel Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy Posted on October 20, 2014 by tsuperadmin -